Skip to main content
. 2022 Dec 30;59(1):86. doi: 10.3390/medicina59010086

Figure 2.

Figure 2

GPC3 expression in various types of experimental controls. (A) No GPC3 immunostaining was found in intraductal carcinoma tissue treated with normal goat serum instead of GPC3 primary antibody (negative control); (B) GPC3 expression was exhibited in intraductal carcinoma tissue incubated with GPC3 primary antibody; (C) no GPC3 expression was found in intraductal carcinoma tissue incubated with peptide-blocked primary antibody; (D) high GPC3 expression was displayed in hepatocellular carcinoma tissue treated with GPC3 primary antibody (positive control); and (E) weak GPC3 expression was determined in hepatocellular carcinoma tissue incubated with peptide-blocked primary antibody. Magnification (×400).